1. In Vitro Activity of Bedaquiline against Rapidly Growing Nontuberculous Mycobacteria. Aguilar-Ayala, D.A., M. Cnockaert, E. Andre, K. Andries, Y.M.J.A. Gonzalez, P. Vandamme, J.C. Palomino, and A. Martin. Journal of Medicinal Microbiology, 2017. 66(8): p. 1140-1143. PMID[28749330].
[PubMed]. TB_08_2017.
2. Novel Drug Targets for Mycobacterium tuberculosis: 2-Heterostyrylbenzimidazoles as Inhibitors of Cell Wall Protein Synthesis. Anguru, M.R., A.K. Taduri, R.D. Bhoomireddy, M. Jojula, and S.K. Gunda. Chemistry Central Journal, 2017. 11(68): 11pp. PMCID[PMC5524660].
[PubMed]. TB_08_2017.
3. Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides are Valuable Antitubercular Candidates That Evade Innate Efflux Machinery. Azzali, E., D. Machado, A. Kaushik, F. Vacondio, S. Flisi, C.S. Cabassi, G. Lamichhane, M. Viveiros, G. Costantino, and M. Pieroni. Journal of Medicinal Chemistry, 2017. 60(16): p. 7108-7122. PMID[28749666].
[PubMed]. TB_08_2017.
4. Evaluation of Antimycobacterial, Leishmanicidal and Antibacterial Activity of Three Medicinal Orchids of Arunachal Pradesh, India. Bhatnagar, M., N. Sarkar, N. Gandharv, O. Apang, S. Singh, and S. Ghosal. BMC Complementary and Alternative Medicine, 2017. 17(1): p. 379. PMID[28764749]. PMCID[PMC5540558].
[PubMed]. TB_08_2017.
5. Synthesis and Biological Evaluation of Pyrimidinyl Sulphonamide Derivatives as Promising Class of Antitubercular Agents. Bhuva, N.H., P.K. Talpara, P.M. Singala, V.K. Gothaliya, and V.H. Shah. Journal of Saudi Chemical Society, 2017. 21(5): p. 517-527. ISI[000406175000002].
[WOS]. TB_08_2017.
6. Antimicrobial Activity of Illudalane and Alliacane Sesquiterpenes from the Mushroom Gloeostereum incarnatum BCC41461. Bunbamrung, N., C. Intaraudom, A. Dramae, N. Boonyuen, S. Veeranondha, P. Rachtawee, and P. Pittayakhajonwut. Phytochemistry Letters, 2017. 20: p. 274-281.
ISI[000405467600054].
[WOS]. TB_08_2017.
7. Synthesis, Antibacterial, Antifungal, Antimycobacterial Activity Evaluation of Novel 1,2,4-Triazole Derivatives Bearing 4-Aminophenyl Moiety. Cavusoglu, B.K., L. Yurttas, M.Y. Cankilic, and Z.A. Kaplancikli. Letters in Drug Design & Discovery, 2017. 14(8): p. 938-948. ISI[000405935700010].
[WOS]. TB_08_2017.
8. Synthesis of a 3-Amino-2,3-dihydropyrid-4-one and Related Heterocyclic Analogues as Mechanism-based Inhibitors of BioA, a Pyridoxal Phosphate-dependent Enzyme. Eiden, C.G. and C.C. Aldrich. Journal of Organic Chemistry, 2017. 82(15): p. 7806-7819. PMID[28682613]. PMCID[PMC5590672].
[PubMed]. TB_08_2017.
9. Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products. Felix, C.R., R. Gupta, S. Geden, J. Roberts, P. Winder, S.A. Pomponi, M.C. Diaz, J.K. Reed, A.E. Wright, and K.H. Rohde. Antimicrobial Agents and Chemotherapy, 2017. 61(8): e00743-17. PMID[28607021]. PMCID[PMC5527660].
[PubMed]. TB_08_2017.
10. Antituberculotic Activity of Actinobacteria Isolated from the Rare Habitats. Hussain, A., M.A. Rather, A.M. Shah, Z.S. Bhat, A. Shah, Z. Ahmad, and Q.P. Hassan. Letters in Applied Microbiology, 2017. 65(3): p. 256-264. PMID[28699251].
[PubMed]. TB_08_2017.
11. Synthesis and Structure-Activity Relationships of Novel Fused Ring Analogues of Q203 as Antitubercular Agents. Kang, S., Y.M. Kim, H. Jeon, S. Park, M.J. Seo, S. Lee, D. Park, J. Nam, S. Lee, K. Nam, S. Kim, and J. Kim. European Journal of Medicinal Chemistry, 2017. 136: p. 420-427. PMID[28527405].
[PubMed]. TB_08_2017.
12. In Vitro and in Vivo Activity of Biapenem against Drug-susceptible and Rifampicin-resistant Mycobacterium tuberculosis. Kaushik, A., N.C. Ammerman, R. Tasneen, E. Story-Roller, K.E. Dooley, S.E. Dorman, E.L. Nuermberger, and G. Lamichhane. Journal of Antimicrobial Chemotherapy, 2017. 72(8): p. 2320-2325. PMID[28575382].
[PubMed]. TB_08_2017.
13. Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessus. Kim, T.S., J.H. Choe, Y.J. Kim, C.S. Yang, H.J. Kwon, J. Jeong, G. Kim, D.E. Park, E.K. Jo, Y.L. Cho, and J. Jang. Antimicrobial Agents and Chemotherapy, 2017. 61(9): e02752-16. PMID[28674049]. PMCID[PMC5571369].
[PubMed]. TB_08_2017.
14. Biopharmaceutic Parameters, Pharmacokinetics, Transport and CYP-Mediated Drug Interactions of IIIM-017: A Novel Nitroimidazooxazole Analogue with Anti-tuberculosis Activity. Kour, G., P.P. Singh, A. Bhagat, and Z. Ahmed. European Journal of Pharmaceutical Sciences, 2017. 106: p. 71-78. PMID[28552479].
[PubMed]. TB_08_2017.
15. Prioritization of Natural Compounds against Mycobacterium tuberculosis 3-Dehydroquinate dehydratase: A Combined in-Silico and in-Vitro Study. Lone, M.Y., M. Athar, V.K. Gupta, and P.C. Jha. Biochemical and Biophysical Research Communications, 2017. 491(4): p. 1105-1111. PMID[28789944].
[PubMed]. TB_08_2017.
16. Antituberculosis Compounds from a Deep-sea-derived Fungus Aspergillus Sp. SCSIO Ind09F01. Luo, X., X. Zhou, X. Lin, X. Qin, T. Zhang, J. Wang, Z. Tu, B. Yang, S. Liao, Y. Tian, X. Pang, K. Kaliyaperumal, J.L. Li, H. Tao, and Y. Liu. Natural Product Research, 2017. 31(16): p. 1958-1962. PMID[28068839].
[PubMed]. TB_08_2017.
17. Biosynthesis of Ilamycins Featuring Unusual Building Blocks and Engineered Production of Enhanced Anti-tuberculosis Agents. Ma, J., H. Huang, Y. Xie, Z. Liu, J. Zhao, C. Zhang, Y. Jia, Y. Zhang, H. Zhang, T. Zhang, and J. Ju. Natural Communications, 2017. 8(1): p. 391. PMID[28855504]. PMCID[PMC5577134].
[PubMed]. TB_08_2017.
18. Anti-mycobacterial Alkaloids, Cyclic 3-Alkyl pyridinium Dimers, from the Indonesian Marine Sponge Haliclona sp. Maarisit, W., D.B. Abdjul, H. Yamazaki, H. Kato, H. Rotinsulu, D.S. Wewengkang, D.A. Sumilat, M.M. Kapojos, K. Ukai, and M. Namikoshi. Bioorganic & Medicinal Chemistry Letters, 2017. 27(15): p. 3503-3506. PMID[28601525].
[PubMed]. TB_08_2017.
19. Microwave-assisted Synthesis of 2-Styrylquinoline-4-carboxylic acids as Antitubercular Agents. Muscia, G.C., S.E. Asis, and G.Y. Buldain. Medicinal Chemistry, 2017. 13(5): p. 448-452. PMID[27585570].
[PubMed]. TB_08_2017.
20. Design, Synthesis, and Biological Evaluation of Isothiosemicarbazones with Antimycobacterial Activity. Novotna, E., K. Waisser, J. Kunes, K. Palat, L. Skalova, B. Szotakova, V. Buchta, J. Stolarikova, V. Ulmann, M. Pavova, J. Weber, J. Komrskova, P. Haskova, I. Vokral, and V. Wsol. Archiv der Pharmazie, 2017. 350(8): e1700020. PMID[28635184].
[PubMed]. TB_08_2017.
21. Design, Synthesis and QSAR Studies of 2-Amino benzo[d]thiazolyl Substituted Pyrazol-5-ones: Novel Class of Promising Antibacterial Agents. Palkar, M.B., A. Patil, G.A. Hampannavar, M.S. Shaikh, H.M. Patel, A.M. Kanhed, M.R. Yadav, and R.V. Karpoormath. Medicinal Chemistry Research, 2017. 26(9): p. 1969-1987. ISI[000406602000013].
[WOS]. TB_08_2017.
22. A Novel 6-Benzyl ether benzoxaborole Is Active against Mycobacterium tuberculosis in Vitro. Patel, N., T. O'Malley, Y.K. Zhang, Y. Xia, B. Sunde, L. Flint, A. Korkegian, T.R. Ioerger, J. Sacchettini, M.R.K. Alley, and T. Parish. Antimicrobial Agents and Chemotherapy, 2017. 61(9): e01205-17. PMID[28674058]. PMCID[PMC5571309].
[PubMed]. TB_08_2017.
23. Ring Functionalization and Molecular Hybridization of Quinolinyl pyrazole: Design, Synthesis and Antimycobacterial Activity. Rachakonda, V., S.S. Kotapalli, R. Ummanni, and M. Alla. ChemistrySelect, 2017. 2(22): p. 6529-6534. ISI[000407471900042].
[WOS]. TB_08_2017.
24. First Report on Isolation of 2,3,4-Trihydroxy-5-methylacetophenone from Palmyra Palm (Borassus flabellifer Linn.) Syrup, Its Antioxidant and Antimicrobial Properties. Reshma, M.V., J. Jacob, V.L. Syamnath, V.P. Habeeba, B.S. Dileep Kumar, and R.S. Lankalapalli. Food Chemistry, 2017. 228: p. 491-496. PMID[28317754].
[PubMed]. TB_08_2017.
25. Synthesis of Novel Triazole-incorporated Isatin Derivatives as Antifungal, Antitubercular, and Antioxidant Agents and Molecular Docking Study. Shaikh, M.H., D.D. Subhedar, F.A.K. Khan, J.N. Sangshetti, L. Nawale, M. Arkile, D. Sarkar, and B.B. Shingate. Journal of Heterocyclic Chemistry, 2017. 54(1): p. 413-421. ISI[000394058900051].
[WOS]. TB_08_2017.
26. Synthesis and Biological Evaluation of Hybrid 1,5-and 2,5-Disubstituted indoles as Potentially New Antitubercular Agents. Soares, A., M.S. Estevao, M.M.B. Marques, V. Kovalishyn, D. Latino, J. Aires-de-Sousa, J. Ramos, M. Viveiros, and F. Martins. Medicinal Chemistry, 2017. 13(5): p. 439-447. PMID[28185538].
[PubMed]. TB_08_2017.
27. The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling. Sogi, K.M., K.A. Lien, J.R. Johnson, N.J. Krogan, and S.A. Stanley. ACS Infectious Diseases, 2017. 3(8): p. 564-574. PMID[28537707].
[PubMed]. TB_08_2017.
28. Synthesis and Biological Evaluation of 1,2,4-Triazole-3-thione and 1,3,4-Oxadiazole-2-thione as Antimycobacterial Agents. Sonawane, A.D., N.D. Rode, L. Nawale, R.R. Joshi, R.A. Joshi, A.P. Likhite, and D. Sarkar. Chemical Biology & Drug Design, 2017. 90(2): p. 200-209. PMID[28083914].
[PubMed]. TB_08_2017.
29. 2,6-Difluorobenzamide Inhibitors of Bacterial Cell Division Protein FtsZ: Design, Synthesis, and Structure-Activity Relationships. Straniero, V., C. Zanotto, L. Straniero, A. Casiraghi, S. Duga, A. Radaelli, C. De Giuli Morghen, and E. Valoti. ChemMedChem, 2017. 12(16): p. 1303-1318. PMID[28586174].
[PubMed]. TB_08_2017.
30. Antimicrobial Activity of Organometallic Isonicotinyl and Pyrazinyl Ferrocenyl-derived Complexes. Stringer, T., R. Seldon, N. Liu, D.F. Warner, C. Tam, L.W. Cheng, K.M. Land, P.J. Smith, K. Chibale, and G.S. Smith. Dalton Transactions, 2017. 46(30): p. 9875-9885. PMID[28713884].
[PubMed]. TB_08_2017.
31. Identification and Synthesis of Novel Inhibitors of Mycobacterium ATP Synthase. Surase, Y.B., K. Samby, S.R. Amale, R. Sood, K.P. Purnapatre, P.K. Pareek, B. Das, K. Nanda, S. Kumar, and A.K. Verma. Bioorganic & Medicinal Chemistry Letters, 2017. 27(15): p. 3454-3459. PMID[28587823].
[PubMed]. TB_08_2017.
32. Discovery of New Leads against Mycobacterium tuberculosis Using Scaffold Hopping and Shape Based Similarity. Wavhale, R.D., E.A.F. Martis, P.K. Ambre, B.J. Wan, S.G. Franzblau, K.R. Iyer, K. Raikuvar, K. Macegoniuk, L. Berlicki, S.R. Nandan, and E.C. Coutinho. Bioorganic & Medicinal Chemistry, 2017. 25(17): p. 4835-4844. PMID[28778369].
[PubMed]. TB_08_2017.
33. The Synthesis and Evaluation of Triazolopyrimidines as Anti-tubercular Agents. Zuniga, E.S., A. Korkegian, S. Mullen, E.J. Hembre, P.L. Ornstein, G. Cortez, K. Biswas, N. Kumar, J. Cramer, T. Masquelin, P.A. Hipskind, J. Odingo, and T. Parish. Bioorganic & Medicinal Chemistry, 2017. 25(15): p. 3922-3946. PMID[28576632].
[PubMed]. TB_08_2017.
Patent Citations
34. Preparation of Disubstituted 2-Oxo-octahydropyrrolo[3,4-E][1,3]oxazines as Antibacterial Compds. Cooper, I. and A. Lyons. Patent. 2017. 2017-GB50317 2017137743: 102pp.
[Patent]. TB_08_2017.
35. Preparation of 2-Oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole Derivatives, and Their Use as Antibacterial Compounds. Cooper, I., A. Lyons, D. Orr, J. Kirkham, and K. Blades. Patent. 2017. 2017-GB50318 2017137744: 267pp.
[Patent]. TB_08_2017.
36. An Oxazolidinone for Treatment of Infections with Mycobacterium tuberculosis.Lamichhane, G. and J.T. Ippoliti. Patent. 2017. 2017-US18248 2017143112: 33pp.
[Patent]. TB_08_2017.
37. Preparation of Novel Inhibitors of Bacterial Growth Targeting L,D-Transpeptidases.Lamichhane, G., C.A. Townsend, E. Lloyd, A. Kaushik, P. Kumar, J. Freundlich, S. Li, S. Ekins, and N. Parrish. Patent. 2017. 2017-US15046 2017132321: 86pp.
[Patent]. TB_08_2017.
38. Broad Spectrum Antibacterial Activity of Novel Bisbenzimidazoles Targeting Topoisomerases and the Synergistic Composition of Bisbenzimidazole with Efflux Pump Inhibitors against Pathogenic Bacteria. Tandon, V. and D. Sinha. Patent. 2017. 2017-IN13 2017125944: 31pp.
[Patent]. TB_08_2017.